Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson's Disease with Motor Fluctuations

BACKGROUND: IPX066 is an extended-release (ER) oral formulation of carbidopa-levodopa (CD-LD). Following an initial peak at about one hour, plasma LD concentrations are maintained for about 4-5 hours. OBJECTIVE: To present dosing factors that may affect the successful conversion to ER CD-LD from oth...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Parkinsons Dis
Autori principali: Morgan, John C., Dhall, Rohit, Rubens, Robert, Khanna, Sarita, Gupta, Suneel
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi 2018
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217748/
https://ncbi.nlm.nih.gov/pubmed/30425824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9763057
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi